Department of Pharmacy Practice, University of Charleston School of Pharmacy, Charleston, WV, USA.
Adv Neurobiol. 2024;35:267-285. doi: 10.1007/978-3-031-45493-6_14.
Opioid use disorders have become an epidemic in recent years with rates nearly quadrupling since 1999 according to the US Centers for Disease Control and Prevention (Centers for Disease Control, Wide-ranging online data for epidemiologic research (WONDER). CDC, National Center for Health Statistics, Atlanta. Retrieved December 19, 2017, from http://wonder.cdc.gov, 2016). To understand substance use disorder (SUD) as a disease, many aspects must be studied including the circuitry in the brain, adaptations to neuronal circuitry and neurotransmitters, genetic variations increasing the risk for SUD, and treatments available for SUD. The mechanism in which an exogenous opioid may cause SUD is nearly identical to the mechanism of an endogenous opioid. This chapter reviews the clinical and epidemiological aspects of opioid use disorder, as well as the interactions between endogenous and exogenous opioids. Additionally, this chapter discusses current scientific data regarding genetic variations and mechanisms within brain circuitry and the role of endogenous opioids in substance use disorders generally (and opioid use disorder specifically). Future applications of these data to treatment of substance use disorders are also discussed.
近年来,阿片类药物使用障碍已成为一种流行病症,据美国疾病控制与预防中心(疾病预防控制中心)的数据显示,自 1999 年以来,该病症的发病率几乎翻了两番(疾病预防控制中心,范围广泛的在线数据用于流行病学研究(WONDER)。疾病预防控制中心,国家卫生统计中心,亚特兰大。2017 年 12 月 19 日从 http://wonder.cdc.gov 检索,2016 年)。为了将物质使用障碍(SUD)理解为一种疾病,必须研究许多方面,包括大脑中的电路、神经元电路和神经递质的适应、增加 SUD 风险的遗传变异,以及 SUD 的可用治疗方法。外源性阿片类药物可能导致 SUD 的机制与内源性阿片类药物的机制几乎完全相同。本章回顾了阿片类药物使用障碍的临床和流行病学方面,以及内源性和外源性阿片类药物之间的相互作用。此外,本章还讨论了目前关于大脑电路中遗传变异和机制以及内源性阿片类药物在物质使用障碍(一般而言,特别是阿片类药物使用障碍)中的作用的科学数据。还讨论了将这些数据应用于物质使用障碍治疗的未来应用。